Chargement en cours...
Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD
Reduced GFR in patients with CKD causes systemic accumulation of uremic toxins, which has been correlated with disease progression and increased morbidity. The orally administered spherical carbon adsorbent AST-120 reduces systemic toxin absorption through gastrointestinal sequestration, which may s...
Enregistré dans:
| Publié dans: | J Am Soc Nephrol |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Nephrology
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4483576/ https://ncbi.nlm.nih.gov/pubmed/25349205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2014010042 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|